![Brigitte Robertson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brigitte Robertson
Hoofd Techniek/Wetenschap/O&O bij Yumanity, Inc.
Actieve functies van Brigitte Robertson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Yumanity, Inc.
![]() Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Brigitte Robertson
Eerdere bekende functies van Brigitte Robertson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Neurovance, Inc.
![]() Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-07-2014 | 01-12-2015 |
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01-03-2010 | 01-07-2014 |
YUMANITY THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | - | - |
Children's Community Pediatrics | Corporate Officer/Principal | 02-01-2001 | 02-01-2001 |
Opleiding van Brigitte Robertson
Georgia Health Sciences University | Doctorate Degree |
Georgia State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Children's Community Pediatrics | |
Neurovance, Inc.
![]() Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
Yumanity Therapeutics, Inc.
![]() Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
Yumanity, Inc.
![]() Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Brigitte Robertson
- Ervaring